Changeflow GovPing Healthcare & Life Sciences DePaul University Variance Application
Routine Notice Added Final

DePaul University Variance Application

Email

Summary

The FDA has posted a variance application submitted by DePaul University's Idea Realization Laboratory. The document is available for review on the Regs.gov platform. No specific compliance actions or deadlines are indicated for other entities.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The Food and Drug Administration (FDA) has made available a variance application submitted by DePaul University's Idea Realization Laboratory. This application, identified under docket number FDA-2026-V-1761-0001, pertains to a specific request for a variance, though the exact nature of the variance and its regulatory implications are not detailed in the provided information.

As this appears to be an informational posting of a submitted application, there are no immediate required actions or compliance deadlines for regulated entities. Compliance officers should note this filing for awareness, particularly if their organization operates within similar research or development contexts that might be affected by future FDA decisions related to this variance.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 1

Variance Application from DePaul University, Idea Realization Laboratory

More Information
- Author(s) CDRH
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2026-V-1761-0001
Docket
FDA-2026-V-1761-0001

Who this affects

Applies to
Educational institutions Drug manufacturers Medical device makers
Industry sector
6111 Higher Education 3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Regulatory Variance Applications
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Compliance frameworks
FDA 21 CFR Part 11
Topics
Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!